Aurobindo Pharma inks pact with not-for-profit to supply HIV drugs

Written by Maha Lakshmi | Mahalakshmi | Mahalakshmi | MAHALAKSHMI | krishna | Hyderabad | Updated: Jun 27 2013, 05:32am hrs
Aurobindo Pharma, a key producer of generic medicines, has signed an agreement with the Geneva-based Medicines Patent Pool (MPP) that will allow the company to produce key medicines for treatment of HIV-affected children. The agreement will also enhance access to critical HIV medicines in developing countries, particularly to new

formulations.

Medicines Patent Pool is a non-profit organisation created to contribute to the scaling up of access to treatment for HIV/AIDS, malaria and tuberculosis, primarily for people in low-income countries besides increasing access to HIV/AIDS medications in developing markets. The Pool operates a scheme in which pharmaceutical patent holders voluntarily licence their drugs to generic manufacturers, who then produce more affordable versions for patients in poorer countries.

Through a patent licence with the MPP, Aurobindo can now supply medicines containing abacavir in 118 countries where 98.7% of children living with HIV reside. Abacavir is recommended by the WHO for treatment of paediatric HIV.